US$ 28.14
semaglutide no longer compounded The Risks of Products Demand Rising for 'Bootlegged' Weight-Loss
Description
In one study, people who combined a GLP-1 medication with supervised exercise were more likely to maintain at least 10% weight loss one year after stopping treatment compared with those who used medication alone

GLP-1 receptor agonist versus DPP-4 inhibitor and kidney and cardiovascular outcomes in clinical practice in type-2 diabetes
Sakai, So

Its not about deprivation

Changes in diet, stress, sleep, activity level, or dose timing can influence hunger signals

Step Two Addressing the Change focuses on helping patients address the specific mechanisms maintaining their manifestations of BED